Douglas T. Sheehy, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 1,875 shares at $39.44 ($74K) on 2017-12-26, disclosed to the SEC on 2017-12-28.
Open-market sale of $74k AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AIMT | SELL | 2018-05-24 | $54K | — | Filing → |
| AIMT | SELL | 2018-03-06 | $129K | — | Filing → |
| AIMT | SELL | 2018-02-07 | $118K | — | Filing → |